178 related articles for article (PubMed ID: 38695983)
21. Hypoxic conditions induce a cancer-like phenotype in human breast epithelial cells.
Vaapil M; Helczynska K; Villadsen R; Petersen OW; Johansson E; Beckman S; Larsson C; Påhlman S; Jögi A
PLoS One; 2012; 7(9):e46543. PubMed ID: 23029547
[TBL] [Abstract][Full Text] [Related]
22. Mammary stem cells and breast cancer--role of Notch signalling.
Farnie G; Clarke RB
Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349
[TBL] [Abstract][Full Text] [Related]
23. Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations.
Communal L; Vilasco M; Hugon-Rodin J; Courtin A; Mourra N; Lahlou N; Le Guillou M; Perrault de Jotemps M; Chauvet MP; Chaouat M; Pujol P; Feunteun J; Delaloge S; Forgez P; Gompel A
Oncotarget; 2016 Jul; 7(29):45317-45330. PubMed ID: 27246982
[TBL] [Abstract][Full Text] [Related]
24. Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.
Lindahl G; Saarinen N; Abrahamsson A; Dabrosin C
Cancer Res; 2011 Jan; 71(1):51-60. PubMed ID: 21097717
[TBL] [Abstract][Full Text] [Related]
25. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
26. Weighing the Risk: effects of Obesity on the Mammary Gland and Breast Cancer Risk.
Hillers-Ziemer LE; Arendt LM
J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):115-131. PubMed ID: 32519090
[TBL] [Abstract][Full Text] [Related]
27. Compressive stress-mediated p38 activation required for ERα + phenotype in breast cancer.
Munne PM; Martikainen L; Räty I; Bertula K; Nonappa ; Ruuska J; Ala-Hongisto H; Peura A; Hollmann B; Euro L; Yavuz K; Patrikainen L; Salmela M; Pokki J; Kivento M; Väänänen J; Suomi T; Nevalaita L; Mutka M; Kovanen P; Leidenius M; Meretoja T; Hukkinen K; Monni O; Pouwels J; Sahu B; Mattson J; Joensuu H; Heikkilä P; Elo LL; Metcalfe C; Junttila MR; Ikkala O; Klefström J
Nat Commun; 2021 Nov; 12(1):6967. PubMed ID: 34845227
[TBL] [Abstract][Full Text] [Related]
28. Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression.
Martinson HA; Jindal S; Durand-Rougely C; Borges VF; Schedin P
Int J Cancer; 2015 Apr; 136(8):1803-13. PubMed ID: 25187059
[TBL] [Abstract][Full Text] [Related]
29. Stromal Gas6 promotes the progression of premalignant mammary cells.
Gomes AM; Carron EC; Mills KL; Dow AM; Gray Z; Fecca CR; Lakey MA; Carmeliet P; Kittrell F; Medina D; Machado HL
Oncogene; 2019 Apr; 38(14):2437-2450. PubMed ID: 30531835
[TBL] [Abstract][Full Text] [Related]
30. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.
Palaniappan M; Edwards D; Creighton CJ; Medina D; Conneely OM
PLoS One; 2018; 13(3):e0194913. PubMed ID: 29590203
[TBL] [Abstract][Full Text] [Related]
31. Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.
Jordan VC
Breast Cancer Res Treat; 1995; 36(3):267-85. PubMed ID: 8573710
[TBL] [Abstract][Full Text] [Related]
32. Stroma modifies relationships between risk factor exposure and age-related epithelial involution in benign breast.
Chollet-Hinton L; Puvanesarajah S; Sandhu R; Kirk EL; Midkiff BR; Ghosh K; Brandt KR; Scott CG; Gierach GL; Sherman ME; Vachon CM; Troester MA
Mod Pathol; 2018 Jul; 31(7):1085-1096. PubMed ID: 29463881
[TBL] [Abstract][Full Text] [Related]
33. Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage.
Masood S
Clin Lab Med; 2005 Dec; 25(4):827-43, viii-ix. PubMed ID: 16308095
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
35. Mammographic density, MRI background parenchymal enhancement and breast cancer risk.
Pike MC; Pearce CL
Ann Oncol; 2013 Nov; 24 Suppl 8(Suppl 8):viii37-viii41. PubMed ID: 24131968
[TBL] [Abstract][Full Text] [Related]
36. Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217.
Northey JJ; Barrett AS; Acerbi I; Hayward MK; Talamantes S; Dean IS; Mouw JK; Ponik SM; Lakins JN; Huang PJ; Wu J; Shi Q; Samson S; Keely PJ; Mukhtar RA; Liphardt JT; Shepherd JA; Hwang ES; Chen YY; Hansen KC; Littlepage LE; Weaver VM
J Clin Invest; 2020 Nov; 130(11):5721-5737. PubMed ID: 32721948
[TBL] [Abstract][Full Text] [Related]
37. Human breast cancer cells are redirected to mammary epithelial cells upon interaction with the regenerating mammary gland microenvironment in-vivo.
Bussard KM; Smith GH
PLoS One; 2012; 7(11):e49221. PubMed ID: 23155468
[TBL] [Abstract][Full Text] [Related]
38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
39. Toward a physiological approach to breast cancer prevention.
Russo J; Russo IH
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):353-64. PubMed ID: 8061586
[TBL] [Abstract][Full Text] [Related]
40. CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer.
Svensson S; Abrahamsson A; Rodriguez GV; Olsson AK; Jensen L; Cao Y; Dabrosin C
Clin Cancer Res; 2015 Aug; 21(16):3794-805. PubMed ID: 25901081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]